Becton Dickinson & CoBDX

NYSEHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$183.82
Market cap
$50.1B
P/E
53.2x
Revenue (TTM)
$23.3B
Net income
$941.0M
Dividend yield
2.16%
1-year total return
32.7%
Net margin
4.0%
Revenue growth
17.4%
Debt / equity
0.69x

What Becton Dickinson & Co does.

Becton, Dickinson and Company (also referred to herein as "BD") was incorporated under the laws of the State of New Jersey in November 1906, as successor to a New York business started in 1897. BD’s executive offices are located at 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, and its telephone number is (201) 847-6800. All references in this Form 10-K to "BD", "the Company", "we", "our" or "us" refer to Becton, Dickinson and Company and its domestic and foreign subsidiaries, unless otherwise indicated by the context.

BD is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. We provide customer solutions that are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology care; enhancing the diagnosis of infectious diseases and cancers; and advancing cellular research and applications.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$16.1B$19.1B$18.9B$19.4B$20.2B$21.8B
Net income$874.0M$2.1B$1.8B$1.5B$1.7B$1.7B
Free cash flow$2.8B$3.5B$1.5B$2.1B$3.1B$2.7B

More on BDX.

Figures from Becton Dickinson & Co's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.